The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease

Journal of Clinical Gastroenterology

Volumn 38, Issue 9, 2004, Pages 772-775

  Meyer, Angela M ^a   Ramzan, Nizar N ^a   Loftus Jr , Edward V ^b   Heigh, Russell I ^a   Leighton, Jonathan A ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Clostridium difficile; Crohn's disease; Inflammatory bowel diseases; Relapses; Stool studies

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; METRONIDAZOLE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CAMPYLOBACTER JEJUNI; CLOSTRIDIUM DIFFICILE; CROHN DISEASE; ENTERITIS; ENZYME IMMUNOASSAY; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PLESIOMONAS SHIGELLOIDES; PRIORITY JOURNAL; RELAPSE; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAMPYLOBACTER JEJUNI; CLOSTRIDIUM DIFFICILE; FECES; FEMALE; GLUCOCORTICOIDS; HOSPITALIZATION; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PLESIOMONAS; PREDNISOLONE; RECURRENCE; SULFASALAZINE;

EID: 4644299551     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000139057.05297.d6     Document Type: Article

References (26)

1. Tedesco FJ, Moore S. Infectious diseases mimicking inflammatory bowel disease. Am Surg. 1982;48:243-249.
2. Tedesco FJ, Hardin RD, Harper RN, et al. Infectious colitis endoscopically simulating inflammatory bowel disease: a prospective evaluation. Gastrointest Endosc. 1983;29:195-197.
3. Bolton RP, Sherriff RJ, Read AE. Clostridium difficile associated diarrhoea: a role in inflammatory bowel disease? Lancet. 1980;1:383-384.
4. Trnka YM, LaMont JT. Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology. 1981;80:693-696.
5. Gryboski JD. Clostridium difficile in inflammatory bowel disease relapse. J Pediatr Gastroenterol Nutr. 1991;13:39-41.
6. Weber P, Koch M, Heizmann WR, et al. Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol. 1992;14:302-308.
7. Kochhar R, Ayyagari A, Goenka MK, et al. Role of infectious agents in exacerbations of ulcerative colitis in India: a study of Clostridium difficile. J Clin Gastroenterol. 1993;16:26-30.
8. Dorman SA, Liggoria E, Winn WC Jr, et al. Isolation of Clostridium difficile from patients with inactive Crohn's disease. Gastroenterology. 1982;82:1348-1351.
9. Burke DA, Axon AT. Clostridium difficile, sulphasalazine, and ulcerative colitis. Postgrad Med J. 1987;63:955-957.
10. Bayerdorffer E, Hochter W, Schwarzkopf-Steinhauser G, et al. Bioptic microbiology in the differential diagnosis of enterocolitis. Endoscopy. 1986;18:177-181.
11. Brown WJ, Hudson MJ, Patrick S, et al. Search for enteric microbial pathogens in patients with ulcerative colitis. Digestion. 1992;53:121-128.
12. Meyers S, Mayer L, Bottone E, et al. Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology. 1981;80:697-770.
13. Greenfield C, Aguilar Ramirez JR, Pounder RE, et al. Clostridium difficile and inflammatory bowel disease. Gut. 1983;24:713-717.
14. Hyams JS, McLaughlin JC. Lack of relationship between Clostridium difficile toxin and inflammatory bowel disease in children. J Clin Gastroenterol. 1985;7:387-390.
15. Rolny P, Jarnerot G, Mollby R. Occurrence of Clostridium difficile toxin inflammatory bowel disease. Scand J Gastroenterol. 1983;18:61-64.
16. LaMont JT, Trnka YM. Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease. Lancet. 1980;1:381-383.
17. Lee DK, Cooper BT, Barbezat GO. Clostridium difficile toxin in chronic idiopathic colitis. N Z Med J. 1986;99:620-622.
18. Goodman MJ, Pearson KW, McGhie D, et al. Campylobacter and Giardia lamblia causing exacerbation of inflammatory bowel disease. Lancet. 1980;2:1247.
19. Bartlett JG. Pathogenesis and treatment of pseudomembranous enterocolitis. Front Gastrointest Res. 1986;13:370-386.
20. Seaver RL. Screening for Clostridium difficile in chronic inflammatory bowel disease in relapse: Is it helpful? Is it cost efficient? J Clin Gastroenterol. 1986;8:397-400.
21. McFarland LV, Mulligan ME, Kwok RY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320:204-210.
22. Keighley MR, Youngs D, Johnson M, et al. Clostridium difficile toxin in acute diarrhoea complicating inflammatory bowel disease. Gut. 1982;23:410-414.
23. Tremaine WJ, Bille J, Huizenga KA, et al. Factors which influence the occurrence of Clostridium difficile infections in inflammatory bowel disease (IBD). Gastroenterology. 1983;4:1337.
24. Trnka YM, Lamont JT. Clostridium difficile colitis. Adv Intern Med. 1984;29:85-107.
25. Johnson S, Clabots CR, Linn FV, et al. Nosocomial Clostridium difficile colonisation and disease. Lancet. 1990;336:97-100.
26. Bartlett JG. Clostridium difficile and inflammatory bowel disease. Gastroenterology. 1981;80:863-865.